This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

United Kingdom | EN-GB

Cortex - Life Sciences Insights

Anna Ward

Associate, DLA Piper

About me

18 Feb, 2022

Clinical Trial Regulations in the EU – how will the UK follow?

By Kate Black

The European Medicines Agency has confirmed that the new Clinical Trials Regulation is now in effect as of 31 January 2022. Please see...

13 Dec, 2021

Do medical devices have systematic bias?

By Kate Black Anna Ward

An investigation has been launched by the UK’s Department of Health and Social Care (“DHSC”) with the overall aim of improving healthcare...

22 Mar, 2021

The future regulation of medical devices in the UK under the Medicines and Medical Devices Act 2021

By Kate Black Anna Ward

The Medicines and Medical Devices Act 2021 (the “MMD Act”) was granted royal assent on 11th February 2021. The MMD Act confers broad...

DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.